MGC blazes trail for London-listed cannabis companies

MGC Pharmaceuticals Ltd (LON: MXC) has become the first cannabis-related company to gain a Main Market listing following the clarification of the rules last year. The shares got off to a strong start.

The Australia-based biopharma company was already trading on ASX, following a reverse takeover in 2016, prior to the standard listing. One-fifth of the enlarged share capital was issued in the placing, which raised £6.5m at 1.475p a share. The costs of the flotation were £500,000. The market capitalisation was £32.9m.

Figures

In the year to June 2020, revenues were A$2.08m, while the loss was A$18.8m. Admittedly, there was a write-off of A$5.1m and a fair value loss on financial instruments of A$2.1m. Even so, gross profit was A$175,000 which barely covers any operating expenses.

...

Previous articleJP Morgan will ‘at some point’ trade bitcoin
Next articleDr Martens gets ahead of itself
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.